SlideShare a Scribd company logo
1 of 65
Download to read offline
November 14-15, 2013
3  understanding and applying epidemiology hb lead-conf
Cris A. Williams, PhD
ENVIRON

Gary H. Abelson
Hiscock & Barclay LLP

Nicholas Szokoly
Law Offices of Evan K. Thalenberg, P.A.

Karl Kieburtz, MD, MPH
University of Rochester Medical Center
Observational
case series – clinical observation
ecologic associations – existing data
cross sectional (prevalence) – existing/new data
case-control – new data
cohort – retrospective – existing/new data
prospective – new data
Interventional
non-randomized trial
randomized, controlled trials
Major:

Temporal
Biological Plausibility
Consistency
Alternative Explanations Explored

Other:

Dose-response Relationship
Strength of Association
Cessation Effects
Gordis 1990
Intended to answer the following questions:
Does the agent get to where it may exert injury?
At a sufficient concentration?
In a biologically active form?
Does it engage the target of interest?
Does it influence downstream
biology/pharmacology?
At what dose?
Studies that are designed
to show that an
exposure/agent modifies
a health state
• Randomization
• Blinding to treatment

Attempts to reduce bias and to
improve the quality of evidence.
Medicine is always confronted with
estimating what the benefits and
toxicities of interventions might be
in a specific patient, given the
evidence available from
populations, usually with little data
about ‘matched’ individuals
Karch and Lasangna
Widely used in assessing adversity
Uncommon in thinking about benefit
Principles are the same










Karl’s topic – Basics of Clinical Trials/How
Medicine Looks at Causation
Introduction to Epidemiology
Epi Study Designs and Strengths/Limitations
Karl’s topic – How to Determine Causation in
an Individual
Lead Studies Overview
Lead Studies from the Plaintiffs’ Perspective
Lead Studies from the Defense Perspective




Definition – study of occurrence of
disease in populations
Subtypes according to exposure/agent
◦ Biological – i.e., infectious disease (cholera)
◦ Environmental

 Natural environment (radon, asbestos, arsenic,
lead)
 Man-made or “anthropogenic”, incl. occupational
(e.g., benzene but also asbestos, arsenic, lead)


Descriptive studies

◦ For hypothesis generation/identification of risk
factors
◦ Use data/information from readily-available sources
(census, disease registries, vital stats)
◦ Cannot establish causal associations between
exposure and disease
◦ Two subtypes: ecological; cross-sectional



Analytical studies

◦ Hypothesis testing
◦ Quantify relative risk of disease
◦ Can establish causal associations between exposure
and disease
◦ Two subtypes: case-control; cohort




Compare outcome frequencies between
different groups during the same time period
or in the same population at different time
periods
Example – birth weight distributions in two
different regions with different levels of
arsenic in drinking water



No information on individuals’ exposure



No control of confounding (e.g., smoking)






Presence or absence of both exposure and
outcome are assessed simultaneously; i.e., a
“snapshot”
Example – study of infertility and psychological
stress
Cannot distinguish whether exposure preceded
outcome


Subjects selected on the basis of whether they
have (cases) or don’t have (controls) a specific

outcome







Example – study of lung cancer cases and
controls and residential radon exposure
Good for diseases with long latency periods
and for rare diseases
Time- and cost-efficient
Susceptible to bias
◦ Selection (e.g., hospital admits)
◦ Recall (e.g., regarding exposure)










A group of individuals are defined on the basis of the
presence or absence of exposure (e.g., worker studies)
Prospective – cohort identified and followed forward in
time (exposure has not yet occurred)
Retrospective – cohort identified and traced backward in
time (exposure had already occurred)
Longitudinal – cohort is the same individuals tracked
forward or backward

Most studies relating lead exposure to IQ are
longitudinal retrospective studies
Study Type

Strengths

Limitations

Ecological

Quick, inexpensive, uses readilyavailable information.

No exposure information, doesn’t
control for confounding.

Cross-sectional

Quick, inexpensive, can provide
valuable information on health
status of a population.

Cannot determine whether
exposure preceded or resulted
from disease.

Case-control

Good for diseases with long
latency periods and for rare
disease, time- and cost-efficient,
can examine multiple etiologic
factors for a single disease.

Good for rare diseases, temporal
relationship between exposure
and disease difficult to establish,
results may be biased (selection
and recall).

Cohort

Good for rare exposures, can
assess multiple effects of a single
exposure and temporal
relationship between exposure
and disease, minimizes bias,
allows for determination of
disease incidence rates.

Not good for rare diseases,
expensive and time-consuming
(prospective), requires availability
of adequate records
(retrospective), susceptible to loss
to follow up.
Source: Nielsen and Jensen (2005).


Dozens of studies relating blood lead and
neurobehavior/cognitive development in humans and
animals



Dating from the late 1970’s



Key studies/reviews
◦ Needleman and Gatsonis (1990) – Low-level Lead Exposure and
the IQ of Children. A Meta-analysis of Modern Studies (JAMA
263:673-678)
◦ Canfield et al. (2003a) – Intellectual Impairment in Children with
Blood Lead Concentrations Below 10 µg per Deciliter (N Engl J
Med 348:1517-1526)
◦ Lanphear et al. (2005) – Low-level Environmental Lead Exposure
and Children’s Intellectual Function: An International Pooled
Analysis (Environ Health Perspect 113:894–899)


Key reviews/commentary
◦ Kaufman (2001a) – Do Low Levels of Lead Produce IQ Loss in Children?: A Careful
Examination of the Literature? (Archives of Clinical Neuropsychology 16:303-341)
◦ Needleman and Bellinger (2001) – Studies of Lead Exposure and the Developing
Central Nervous System: A Reply to Kaufman (Archives of Clinical Neuropsychology
16:359-374)
◦ Kaufman (2001b) – How Dangerous are Low (Not Moderate or High) Doses of Lead
for Children' s Intellectual Development? (Archives of Clinical Neuropsychology
16:403-431)







Early studies – established the effect
Later studies – establishing the effect at increasingly lower
PbB
“Plaintiff” studies and “Defense” studies
3  understanding and applying epidemiology hb lead-conf








The hypothesis that Pb damages children's
brains at low doses is widely accepted
There is no safe level of PbB/a linear inverse
relationship exists between PbB and
intelligence test scores (IQ) – i.e., no
threshold
Correlations between PbB and IQ are socially
relevant
Correlations between PbB and IQ remain
when confounders were considered
The hypothesis that Pb affects IQ at low
doses is widely accepted (EPA 2013)




12 major prospective studies, 1992-2011
3 cross-sectional studies, 1987-2011
4 “meta” analyses/pooled studies, 19902005
There is no safe level of blood lead/a linear
inverse relationship exists between PbB and
intelligence test scores (IQ) – i.e., no threshold








Boston cohort – PbB = 1-9.3 μg/dL (Schwartz 1994)
Rochester cohort – PbB = 0.5-8.4 μg/dL (Canfield et al.
2003b)
Mexico City cohort – PbB = 0.8-4.9 μg/dL (Téllez-Rojo
2008)
North Carolina cohort – PbB = 2 μg/dL (Miranda et al.
2009)*

*EOG (4th grade) as a surrogate for IQ.
Correlations between PbB and IQ are socially
relevant (Needleman and Bellinger 2001)






 shift of IQ scores occurred across entire
distribution of IQ scores
 shift in median scores of 6 points
associated with 4-fold increase in IQ scores
<80
5% of population failed to achieve superior IQ
scores >125
Exposures in early childhood associated with
7x increase in high school failure and a 6x
increase in reading disabilities
Correlations between PbB and IQ remain when
confounders were considered (Needleman and
Bellinger 2001)





Prospective studies controlled for at least
some measure of maternal IQ
Most studies controlled for at least global
measures of SES; in some cases controlled for
home environment more specifically (e.g., via
HOME, FACES, etc.)
Persons administering the IQ tests in most of
the studies were adequately trained in
psychometrics





The hypothesis that Pb affects IQ at low
doses is controversial
There is a level of PbB below which effects on
IQ are insignificant – i.e., a threshold
Correlations between PbB and IQ are not
socially relevant
Correlations between PbB and IQ largely
disappear when confounders were considered
The hypothesis that Pb consistently affects
IQ at low doses is controversial







Inconsistency in IQ findings both between studies and
within studies (Ernhart 1995)
Studies purported to be “low-lead” studies in humans
(and animals) are actually moderate- to high-lead
studies (Kaufman 2001b)
Gender-specific effects – some studies showed > effects
in girls than boys; others demonstrated the opposite
(Hebben 2001)
Although many studies report a significant association
between lead and IQ, lead tends to account for a very
small amount of variance in IQ (Bellinger and Dietrich
1994)
There is a level of PbB below which effects on
IQ are insignificant – i.e., a threshold




Assumption of PbB/IQ linearity based not on
actual data but rather on dubious regression
analyses (Kaufman 2001b)
EPA’s Integrated Science Assessment for Lead
(EPA 2013)

◦ Lack of a reference population (PbB in pre-industrial
population) limits ability to identify a threshold
◦ “. . . the current evidence does not preclude the
possibility of a threshold for neurodevelopmental
effects in children existing with lower blood levels
than those currently examined.”
Correlations between PbB and IQ are not socially relevant
(Kaufman 2001b)






A few IQ points is well within a reasonable band of error
around the observed score
The usual IQ loss attributed to low PbB is similar in
magnitude to the 2- to 3-point mean gender difference
(favoring males)
IQ score is meaningless without measurement of other
aspects of intellectual functioning – e.g., creativity, social
intelligence, practical intelligence, adaptive behavior,
mechanical ability, etc.
Correlations between PbB and IQ largely
disappear when confounders were
considered (Kaufman 2001a and b)


For the 26 PbB/IQ studies where
confounders may have affected the
results:
◦
◦
◦
◦
◦

12 used only a global assessment of SES
17 used a “poor” or no measure of maternal IQ
24 did not test father’s IQ
24 did not control for persistent otitis media
18 did not control for pregnancy risk factors
(e.g., maternal drug use/abuse, smoking)
Difference in Maternal IQ Scores
Difference in HOME
Scores

Difference in Parental
Years of Education

7.5

3.6

0.75

7.58

9.42

11.27

1.5

9.11

10.96

12.81

2.25

10.65

12.50

14.35

0.75

11.77

13.62

15.46

1.5

13.30

15.15

17.00

2.25

14.84

16.69

18.54

0.75

15.96

17.81

19.65

1.5

17.50

19.34

21.19

2.25

19.03

20.88

22.73

7.2

10.8

15

22.5

Difference in Child IQ Scores

Source: Mink et al. (2004).


An additional “threat” to the validity of the
Pb/IQ studies are variables associated
with intelligence that are either unknown
or unmeasurable – the “Flynn effect”
(Kaufman 2001a)
◦ 3 point-per-decade gain in IQ beginning in the
1930’s and continuing to this day
◦ Exposure to technology/mass media?
◦ Parenting/increased awareness of importance
of providing cognitive stimulation in infancy?
◦ Improved nutrition?
















Bellinger, D., and Dietrich, K. N. 1994. Low-level lead exposure and cognitive
function in children. Pediatric Annals 23:601-605.
Canfield, R.L., Henderson, C.R. Jr., Cory-Slechta, D.A., Cox, C., Jusko, T.A., and
Lanphear, B.P. 2003a. Intellectual Impairment in children with blood lead
concentrations below 10 µg per deciliter. N Engl J Med 348:1517-1526.
Canfield, R.L.., Kreher, D.A., Cornwell, C., and Henderson, C.R., Jr. 2003b. Low-level
lead exposure, executive functioning, and learning in early childhood. Child
Neuropsychol 9:35-53.
EPA. 2013. Integrated Science Assessment for Lead. EPA/600/R-10/075F. Office
of Research and Development, National Center for Environmental Assessment,
Research Triangle Park, NC.
Ernhart, C.B. 1995. Inconsistencies in the lead-effects literature exist and cannot
be explained by "effect modification". Neurotoxicol Teratol. 17(3):227-233.
Hebben, H. 2001. Low lead levels and neuropsychological assessment: Let us not
be mislead. Archives of Clinical Neuropsychology 16:353-357.
Kaufman, A.S. 2001a. Do low levels of lead produce IQ loss in children?: A careful
examination of the literature? Archives of Clinical Neuropsychology 16:303-341.
Kaufman, A.S. 2001b. How dangerous are low (not moderate or high) doses of lead
for children' s intellectual development? Archives of Clinical Neuropsychology
16:403-431.














Lanphear, B.P., Hornung, R., Khoury, J., Yolton, K., Baghurst, P., Bellinger, D.C.,
Canfield, R.L., Dietrich, K.N., Bornschein, R., Greene, T., Rothenberg, S.J.,
Needleman, H.L., Schnaas, L., Wasserman, G., Graziano, J., and Roberts, R. 2005.
Low-level environmental lead exposure and children’s intellectual function: An
international pooled analysis (Environ Health Perspect 113:894–899.
Mink, P.J., Goodman, M., Barraj, L.M., Imrey, H., Kelsh, M.A., and Yager. J. 2004.
Evaluation of uncontrolled confounding in studies of environmental exposures and
neurobehavioral testing in children. Epidemiology 15(4):385-393.
Miranda, M.L., Kim, D., Reiter, J., Overstreet Galeano, MA., and Maxson, P. 2009.
Environmental contributors to the achievement gap. Neurotoxicology 30:10191024.
Needleman, H.L., and Bellinger, D. 2001. Studies of lead exposure and the
developing central nervous system: A reply to Kaufman. Archives of Clinical
Neuropsychology 16:359-374.
Needleman, H.L., and Gatsonis, C.A. 1990. Low-level lead exposure and the IQ of
children. A meta-analysis of modern studies. JAMA 263(5):673-678.
Nielsen, J.B. and Jensen, T.K. 2005. Environmental Epidemiology. In: Essentials of
Medical Geology – Impacts of the Natural Environment on Public Health. O. Selinus,
Ed. Elsevier.
Schwartz, J. 1994. Low-level lead exposure and children's IQ: A meta-analysis and
search for a threshold. Environ Res 65:42-55..


Téllez-Rojo, M.M., Bellinger, D.C., Arroyo-Quiroz, C., Lamadrid-Figueroa, H.,
Mercado-Garcia, A., Schnaas-Arrieta, L., Wright, RO., Hernandez-Avila, M., and Hu,
H. 2006. Longitudinal associations between blood lead concentrations lower than
10 microg/dL and neurobehavioral development in environmentally exposed
children in Mexico City. Pediatrics 118:e323-e330.
EPIDEMIOLOGIC STUDIES FOR LEAD
WHAT ARE THEY GOOD FOR?
• Can epidemiologic studies
be used “across the board”
to determine whether lead
has affected a particular
individual?
General Causation
v.
Specific Causation
• Population based studies
• They were not designed –
nor could they be – to
determine whether a
specific child has been
affected by lead exposure
Does A equal B?
1. Do all smokers get lung
cancer?
2. Do all football players
sustain brain injuries?
• Epidemiologic Studies may
show “general causation”

• They cannot, by
themselves, get to specific
causation in an individual.
• Lead and IQ –
is there a correlation?

1. Is pre-morbid IQ testing
necessary?
a. In order to make an
intelligent assessment of
whether an individual has
lost IQ points as a result of
exposure to lead there must
be a baseline.
b.Studies that claim to
quantify IQ loss as a result
of exposure to lead are
speculative.
c. Not possible to “assign” a
loss of IQ with any elevated
lead level – only a
comparison between preinjury testing and postinjury assessment can yield
a true measure of
intellectual change.
d. Full scale IQ measure can
be unreliable for
determining a person’s
actual level of cognitive
capability.
e. Neuropsychological testing
is used to test areas
involving memory,
attention , executive
functions, verbal fluency.
f. How does an individual
test in these areas? Have
to look “behind the
numbers”
g. If a child scores low,
medium or high on any
test – does not mean they
would have scored
otherwise had there been
no lead exposure
• There is no specific/single
neuropsychological test or
result that allows for the
conclusion that a specific
child’s lead exposure had
any impact.
2. Confounding Variables
Significant and wellknown risk factors for
the development of
cognitive difficulties
mirror claims of lead
exposure:
a. Low birth weight
b.Maternal pregnancy issues –
drugs/alcohol in utero
exposure
c. Prenatal smoking
d. Parental involvement
e. Structured
environment/lack thereof
f. Abuse issues
1) Mental
2) Physical
3) Sexual
h. Potential foster care
i.

Outside influences

j.

Drug Use by individuals

k. Depression/anxiety
•

Each individual different –
cannot “control” for all
variables

•

Fallacy of argument that
confounding factors are
being counted twice
3. School Performance
a. Attendance – school and
specific classes
b. Homework completion

c. Extra help
d.
e.
f.
g.

Behavior problems
Discipline problems
Drug use
Frequent changes in
school – disruptive
learning
Conclusion
General population studies are
just that, not capable of being
used to determine that any
individual has been affected by
alleged exposure to lead.
3  understanding and applying epidemiology hb lead-conf
3  understanding and applying epidemiology hb lead-conf


ONE OF THE LONGEST EPIDEMIOLOGICAL
LONGITUDINAL STUDIES!

Quit smoking on the advice of
your physician?
 Epidemiological research.

Take Tamiflu in 2009?
 Epidemiological research.



Lead is the most well studied toxin in history.
International pooled analysis:
◦ Data, not average of averages.
◦ Seven participating sites:










Boston, Mass.
Cincinnati, Ohio
Cleveland, Ohio
Mexico City, Mexico
Port Pirie, Australia
Rochester, NY
Yugoslovia

Approximately 1,300 children.


International Pooled Analysis
◦
◦
◦
◦
◦
◦
◦
◦
◦
◦

HOME Inventory
Sex
Birth weight
Birth order
Maternal education
Maternal IQ
Maternal age
Marital status
Prenatal smoking status
Prenatal alcohol use


Q And I think you had said it once best, and tell if it sounds -- you said this, but
just tell me
if you still agree with it, the researchers control for those factors so that the
conclusion of their study is specific to what is the measurable effect that lead has
on IQ loss?
A Correct.
Q And that's in the context of the pooled analysis. And for Needleman, it would
be the researchers controlled for those factors so the conclusion of their study is
specific to what is the measurable effect that lead has on behavior?
A Correct.
Q And so it's incorrect to assume that in order to reach the opinions you have in
this case, that you need administer the HOME test to the plaintiffs to determine
whether or not their lead exposure caused them IQ loss?
A That's correct.
Q It's already been done. That's the point.
A Well, and I'm only giving opinions about what IQ loss I would attribute using
this type of medical literature to this particular child.
Q And I know it sounds pedantic. Just work with me here. But the point that I'm
making is that you don't have to go back in the forensic context and control for all
these variables again. That's why the researchers did it in the first place?
MR. [Lawyer for the Defendant]: Objection.



A

















That's correct. Yes. I agree with that.




If only Johnny with his 65 IQ, reading disorder
and ADHD wouldn’t have missed 30 days his
4th time in 9th grade, it would have all worked
out okay.
Hammond et al., May 2007
◦ Among the top risk factors for dropping out of
middle school and high school:
 Learning disabled
 Low academic achievement
 Retention/over-age for grade

 Multiple retentions have additive effects, dramatically
increasing the risk of dropping out.
3  understanding and applying epidemiology hb lead-conf




















Dr. Cris A. Williams Ph.D., Senior Science Advisor
ENVIRON
850.668.3551
cwilliams@environcorp.com
Gary Abelson
Hiscock & Barclay LLP
585.295.8411
gabelson@hblaw.com
Nicholas Szokoly
Law Offices of Evan K. Thalenberg, P.A.
410.625.9200
nszokoly@ektlaw.com
Dr. Karl Kieburtz MD, MPH
University of Rochester Medical Center
585.275.8762
Karl.Kieburtz@chet.rochester.edu

More Related Content

What's hot

The number of existing functional somatic syndromes (fs ss) is an important r...
The number of existing functional somatic syndromes (fs ss) is an important r...The number of existing functional somatic syndromes (fs ss) is an important r...
The number of existing functional somatic syndromes (fs ss) is an important r...Paul Coelho, MD
 
Literatür1
Literatür1Literatür1
Literatür1TK57338
 
WEON preconference Greenland
WEON preconference GreenlandWEON preconference Greenland
WEON preconference GreenlandBsie
 

What's hot (6)

GENETICS
GENETICSGENETICS
GENETICS
 
ASSOCIATIONS OF GENETIC FACTORS TO HIV/AIDS BEHAVIORS
ASSOCIATIONS OF GENETIC FACTORS TO HIV/AIDS BEHAVIORS ASSOCIATIONS OF GENETIC FACTORS TO HIV/AIDS BEHAVIORS
ASSOCIATIONS OF GENETIC FACTORS TO HIV/AIDS BEHAVIORS
 
The number of existing functional somatic syndromes (fs ss) is an important r...
The number of existing functional somatic syndromes (fs ss) is an important r...The number of existing functional somatic syndromes (fs ss) is an important r...
The number of existing functional somatic syndromes (fs ss) is an important r...
 
Literatür1
Literatür1Literatür1
Literatür1
 
Genetics final
Genetics finalGenetics final
Genetics final
 
WEON preconference Greenland
WEON preconference GreenlandWEON preconference Greenland
WEON preconference Greenland
 

Similar to 3 understanding and applying epidemiology hb lead-conf

Types of clinical studies
Types of clinical studiesTypes of clinical studies
Types of clinical studiesSamir Haffar
 
ANTH336_The Proximate Causes of ADHD
ANTH336_The Proximate Causes of ADHDANTH336_The Proximate Causes of ADHD
ANTH336_The Proximate Causes of ADHDAustin Pittsley
 
Depression And Dementi Depression
Depression And Dementi DepressionDepression And Dementi Depression
Depression And Dementi DepressionSharon Price
 
Mark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disordersMark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disorderswef
 
Returning genetic research results in neurodevelopmental disorders: report an...
Returning genetic research results in neurodevelopmental disorders: report an...Returning genetic research results in neurodevelopmental disorders: report an...
Returning genetic research results in neurodevelopmental disorders: report an...KBHN KT
 
Lecture 2 Research Methods.pptx
Lecture 2 Research Methods.pptxLecture 2 Research Methods.pptx
Lecture 2 Research Methods.pptxAyesha Yaqoob
 
Biomarkers for psychological phenotypes?
Biomarkers for psychological phenotypes?Biomarkers for psychological phenotypes?
Biomarkers for psychological phenotypes?Dorothy Bishop
 
Environmental epidemiology involves the study of human beings. Int.docx
Environmental epidemiology involves the study of human beings. Int.docxEnvironmental epidemiology involves the study of human beings. Int.docx
Environmental epidemiology involves the study of human beings. Int.docxjenkinsmandie
 
Articles bonuck-sleep disordered-breathing-1 (1)
Articles bonuck-sleep disordered-breathing-1 (1)Articles bonuck-sleep disordered-breathing-1 (1)
Articles bonuck-sleep disordered-breathing-1 (1)Claire Ferrari
 
Research Designs
Research DesignsResearch Designs
Research DesignsAravind L R
 
11. Identifying the Elements of the Limitations & ImplicationsGo t
11. Identifying the Elements of the Limitations & ImplicationsGo t11. Identifying the Elements of the Limitations & ImplicationsGo t
11. Identifying the Elements of the Limitations & ImplicationsGo tBenitoSumpter862
 
11. Identifying the Elements of the Limitations & ImplicationsGo t
11. Identifying the Elements of the Limitations & ImplicationsGo t11. Identifying the Elements of the Limitations & ImplicationsGo t
11. Identifying the Elements of the Limitations & ImplicationsGo tSantosConleyha
 
Pathways to wellbeing
Pathways to wellbeingPathways to wellbeing
Pathways to wellbeingAndrew Kemp
 
Final Draft Advanced
Final Draft AdvancedFinal Draft Advanced
Final Draft AdvancedLiam Sprague
 

Similar to 3 understanding and applying epidemiology hb lead-conf (20)

Types of clinical studies
Types of clinical studiesTypes of clinical studies
Types of clinical studies
 
ANTH336_The Proximate Causes of ADHD
ANTH336_The Proximate Causes of ADHDANTH336_The Proximate Causes of ADHD
ANTH336_The Proximate Causes of ADHD
 
Depression And Dementi Depression
Depression And Dementi DepressionDepression And Dementi Depression
Depression And Dementi Depression
 
Asd research
Asd researchAsd research
Asd research
 
Case control study
Case control studyCase control study
Case control study
 
Mark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disordersMark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disorders
 
Returning genetic research results in neurodevelopmental disorders: report an...
Returning genetic research results in neurodevelopmental disorders: report an...Returning genetic research results in neurodevelopmental disorders: report an...
Returning genetic research results in neurodevelopmental disorders: report an...
 
Lecture 2 Research Methods.pptx
Lecture 2 Research Methods.pptxLecture 2 Research Methods.pptx
Lecture 2 Research Methods.pptx
 
Cohort study
Cohort studyCohort study
Cohort study
 
Biomarkers for psychological phenotypes?
Biomarkers for psychological phenotypes?Biomarkers for psychological phenotypes?
Biomarkers for psychological phenotypes?
 
health
healthhealth
health
 
Environmental epidemiology involves the study of human beings. Int.docx
Environmental epidemiology involves the study of human beings. Int.docxEnvironmental epidemiology involves the study of human beings. Int.docx
Environmental epidemiology involves the study of human beings. Int.docx
 
Study design
Study design Study design
Study design
 
Articles bonuck-sleep disordered-breathing-1 (1)
Articles bonuck-sleep disordered-breathing-1 (1)Articles bonuck-sleep disordered-breathing-1 (1)
Articles bonuck-sleep disordered-breathing-1 (1)
 
Research Designs
Research DesignsResearch Designs
Research Designs
 
11. Identifying the Elements of the Limitations & ImplicationsGo t
11. Identifying the Elements of the Limitations & ImplicationsGo t11. Identifying the Elements of the Limitations & ImplicationsGo t
11. Identifying the Elements of the Limitations & ImplicationsGo t
 
11. Identifying the Elements of the Limitations & ImplicationsGo t
11. Identifying the Elements of the Limitations & ImplicationsGo t11. Identifying the Elements of the Limitations & ImplicationsGo t
11. Identifying the Elements of the Limitations & ImplicationsGo t
 
Pathways to wellbeing
Pathways to wellbeingPathways to wellbeing
Pathways to wellbeing
 
Casecontrolstudy
CasecontrolstudyCasecontrolstudy
Casecontrolstudy
 
Final Draft Advanced
Final Draft AdvancedFinal Draft Advanced
Final Draft Advanced
 

More from HB Litigation Conferences

LEGALIZED MARIJUANA | HB EMERGING COMPLEX CLAIMS
LEGALIZED MARIJUANA | HB EMERGING COMPLEX CLAIMSLEGALIZED MARIJUANA | HB EMERGING COMPLEX CLAIMS
LEGALIZED MARIJUANA | HB EMERGING COMPLEX CLAIMSHB Litigation Conferences
 
SOCIAL MEDIA RISKS | HB EMERGING COMPLEX CLAIMS
SOCIAL MEDIA RISKS | HB EMERGING COMPLEX CLAIMSSOCIAL MEDIA RISKS | HB EMERGING COMPLEX CLAIMS
SOCIAL MEDIA RISKS | HB EMERGING COMPLEX CLAIMSHB Litigation Conferences
 
PRIMARY - EXCESS | THE BUSINESS OF LAYERS | HB EMERGING COMPLEX CLAIMS
PRIMARY - EXCESS | THE BUSINESS OF LAYERS | HB EMERGING COMPLEX CLAIMSPRIMARY - EXCESS | THE BUSINESS OF LAYERS | HB EMERGING COMPLEX CLAIMS
PRIMARY - EXCESS | THE BUSINESS OF LAYERS | HB EMERGING COMPLEX CLAIMSHB Litigation Conferences
 
CYBER LIABILITY COVEREAGE | HB EMERGING COMPLEX CLAIMS
CYBER LIABILITY COVEREAGE | HB EMERGING COMPLEX CLAIMSCYBER LIABILITY COVEREAGE | HB EMERGING COMPLEX CLAIMS
CYBER LIABILITY COVEREAGE | HB EMERGING COMPLEX CLAIMSHB Litigation Conferences
 
State of Litigation: Data Breach & Coverage Litigation
State of Litigation: Data Breach & Coverage Litigation State of Litigation: Data Breach & Coverage Litigation
State of Litigation: Data Breach & Coverage Litigation HB Litigation Conferences
 
The Cloud: Insurance Aggregation, Cloud Contracts & Technology
The Cloud: Insurance Aggregation, Cloud Contracts & TechnologyThe Cloud: Insurance Aggregation, Cloud Contracts & Technology
The Cloud: Insurance Aggregation, Cloud Contracts & TechnologyHB Litigation Conferences
 
Attorneys General Perspectives on Data Breaches
Attorneys General Perspectives on Data BreachesAttorneys General Perspectives on Data Breaches
Attorneys General Perspectives on Data BreachesHB Litigation Conferences
 
"Who's Ox is Being Gored? A Comparison of ConsensusDOCS and AIA Form Construc...
"Who's Ox is Being Gored? A Comparison of ConsensusDOCS and AIA Form Construc..."Who's Ox is Being Gored? A Comparison of ConsensusDOCS and AIA Form Construc...
"Who's Ox is Being Gored? A Comparison of ConsensusDOCS and AIA Form Construc...HB Litigation Conferences
 

More from HB Litigation Conferences (20)

LEGALIZED MARIJUANA | HB EMERGING COMPLEX CLAIMS
LEGALIZED MARIJUANA | HB EMERGING COMPLEX CLAIMSLEGALIZED MARIJUANA | HB EMERGING COMPLEX CLAIMS
LEGALIZED MARIJUANA | HB EMERGING COMPLEX CLAIMS
 
GMO | HB EMERGING COMPLEX CLAIMS
GMO | HB EMERGING COMPLEX CLAIMSGMO | HB EMERGING COMPLEX CLAIMS
GMO | HB EMERGING COMPLEX CLAIMS
 
SOCIAL MEDIA RISKS | HB EMERGING COMPLEX CLAIMS
SOCIAL MEDIA RISKS | HB EMERGING COMPLEX CLAIMSSOCIAL MEDIA RISKS | HB EMERGING COMPLEX CLAIMS
SOCIAL MEDIA RISKS | HB EMERGING COMPLEX CLAIMS
 
PRIMARY - EXCESS | THE BUSINESS OF LAYERS | HB EMERGING COMPLEX CLAIMS
PRIMARY - EXCESS | THE BUSINESS OF LAYERS | HB EMERGING COMPLEX CLAIMSPRIMARY - EXCESS | THE BUSINESS OF LAYERS | HB EMERGING COMPLEX CLAIMS
PRIMARY - EXCESS | THE BUSINESS OF LAYERS | HB EMERGING COMPLEX CLAIMS
 
CYBER LIABILITY COVEREAGE | HB EMERGING COMPLEX CLAIMS
CYBER LIABILITY COVEREAGE | HB EMERGING COMPLEX CLAIMSCYBER LIABILITY COVEREAGE | HB EMERGING COMPLEX CLAIMS
CYBER LIABILITY COVEREAGE | HB EMERGING COMPLEX CLAIMS
 
ACAM webinar presentation final v4
ACAM webinar presentation final v4ACAM webinar presentation final v4
ACAM webinar presentation final v4
 
Vendor Contracts & Cyber Risks
Vendor Contracts & Cyber RisksVendor Contracts & Cyber Risks
Vendor Contracts & Cyber Risks
 
Technology to Mitigate Risk
Technology to Mitigate RiskTechnology to Mitigate Risk
Technology to Mitigate Risk
 
Small Entity Cyber Liability
Small Entity Cyber LiabilitySmall Entity Cyber Liability
Small Entity Cyber Liability
 
Payment Card Industry Adjudication Process
Payment Card Industry Adjudication ProcessPayment Card Industry Adjudication Process
Payment Card Industry Adjudication Process
 
London Cyber Risk Perspectives
London Cyber Risk PerspectivesLondon Cyber Risk Perspectives
London Cyber Risk Perspectives
 
State of Litigation: Data Breach & Coverage Litigation
State of Litigation: Data Breach & Coverage Litigation State of Litigation: Data Breach & Coverage Litigation
State of Litigation: Data Breach & Coverage Litigation
 
Dissecting a Data Breach
Dissecting a Data BreachDissecting a Data Breach
Dissecting a Data Breach
 
The Cloud: Insurance Aggregation, Cloud Contracts & Technology
The Cloud: Insurance Aggregation, Cloud Contracts & TechnologyThe Cloud: Insurance Aggregation, Cloud Contracts & Technology
The Cloud: Insurance Aggregation, Cloud Contracts & Technology
 
Data Breach Claims & Loss Update
Data Breach Claims & Loss UpdateData Breach Claims & Loss Update
Data Breach Claims & Loss Update
 
Big Data & Wrongful Collection
Big Data & Wrongful CollectionBig Data & Wrongful Collection
Big Data & Wrongful Collection
 
The Basics of Cyber Insurance
The Basics of Cyber InsuranceThe Basics of Cyber Insurance
The Basics of Cyber Insurance
 
Attorneys General Perspectives on Data Breaches
Attorneys General Perspectives on Data BreachesAttorneys General Perspectives on Data Breaches
Attorneys General Perspectives on Data Breaches
 
Advanced Level Cyber Insurance Coverage
Advanced Level Cyber Insurance CoverageAdvanced Level Cyber Insurance Coverage
Advanced Level Cyber Insurance Coverage
 
"Who's Ox is Being Gored? A Comparison of ConsensusDOCS and AIA Form Construc...
"Who's Ox is Being Gored? A Comparison of ConsensusDOCS and AIA Form Construc..."Who's Ox is Being Gored? A Comparison of ConsensusDOCS and AIA Form Construc...
"Who's Ox is Being Gored? A Comparison of ConsensusDOCS and AIA Form Construc...
 

Recently uploaded

Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
Employability skills, work experience presentation
Employability skills, work experience presentationEmployability skills, work experience presentation
Employability skills, work experience presentationmarwaahmad357
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
Forensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentationForensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentationKavitha Krishnan
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 

Recently uploaded (20)

Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
Employability skills, work experience presentation
Employability skills, work experience presentationEmployability skills, work experience presentation
Employability skills, work experience presentation
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
Forensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentationForensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentation
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 

3 understanding and applying epidemiology hb lead-conf

  • 3. Cris A. Williams, PhD ENVIRON Gary H. Abelson Hiscock & Barclay LLP Nicholas Szokoly Law Offices of Evan K. Thalenberg, P.A. Karl Kieburtz, MD, MPH University of Rochester Medical Center
  • 4. Observational case series – clinical observation ecologic associations – existing data cross sectional (prevalence) – existing/new data case-control – new data cohort – retrospective – existing/new data prospective – new data Interventional non-randomized trial randomized, controlled trials
  • 5. Major: Temporal Biological Plausibility Consistency Alternative Explanations Explored Other: Dose-response Relationship Strength of Association Cessation Effects Gordis 1990
  • 6. Intended to answer the following questions: Does the agent get to where it may exert injury? At a sufficient concentration? In a biologically active form? Does it engage the target of interest? Does it influence downstream biology/pharmacology? At what dose?
  • 7. Studies that are designed to show that an exposure/agent modifies a health state
  • 8. • Randomization • Blinding to treatment Attempts to reduce bias and to improve the quality of evidence.
  • 9. Medicine is always confronted with estimating what the benefits and toxicities of interventions might be in a specific patient, given the evidence available from populations, usually with little data about ‘matched’ individuals
  • 10. Karch and Lasangna Widely used in assessing adversity Uncommon in thinking about benefit Principles are the same
  • 11.        Karl’s topic – Basics of Clinical Trials/How Medicine Looks at Causation Introduction to Epidemiology Epi Study Designs and Strengths/Limitations Karl’s topic – How to Determine Causation in an Individual Lead Studies Overview Lead Studies from the Plaintiffs’ Perspective Lead Studies from the Defense Perspective
  • 12.   Definition – study of occurrence of disease in populations Subtypes according to exposure/agent ◦ Biological – i.e., infectious disease (cholera) ◦ Environmental  Natural environment (radon, asbestos, arsenic, lead)  Man-made or “anthropogenic”, incl. occupational (e.g., benzene but also asbestos, arsenic, lead)
  • 13.  Descriptive studies ◦ For hypothesis generation/identification of risk factors ◦ Use data/information from readily-available sources (census, disease registries, vital stats) ◦ Cannot establish causal associations between exposure and disease ◦ Two subtypes: ecological; cross-sectional  Analytical studies ◦ Hypothesis testing ◦ Quantify relative risk of disease ◦ Can establish causal associations between exposure and disease ◦ Two subtypes: case-control; cohort
  • 14.   Compare outcome frequencies between different groups during the same time period or in the same population at different time periods Example – birth weight distributions in two different regions with different levels of arsenic in drinking water  No information on individuals’ exposure  No control of confounding (e.g., smoking)
  • 15.    Presence or absence of both exposure and outcome are assessed simultaneously; i.e., a “snapshot” Example – study of infertility and psychological stress Cannot distinguish whether exposure preceded outcome
  • 16.  Subjects selected on the basis of whether they have (cases) or don’t have (controls) a specific outcome     Example – study of lung cancer cases and controls and residential radon exposure Good for diseases with long latency periods and for rare diseases Time- and cost-efficient Susceptible to bias ◦ Selection (e.g., hospital admits) ◦ Recall (e.g., regarding exposure)
  • 17.      A group of individuals are defined on the basis of the presence or absence of exposure (e.g., worker studies) Prospective – cohort identified and followed forward in time (exposure has not yet occurred) Retrospective – cohort identified and traced backward in time (exposure had already occurred) Longitudinal – cohort is the same individuals tracked forward or backward Most studies relating lead exposure to IQ are longitudinal retrospective studies
  • 18. Study Type Strengths Limitations Ecological Quick, inexpensive, uses readilyavailable information. No exposure information, doesn’t control for confounding. Cross-sectional Quick, inexpensive, can provide valuable information on health status of a population. Cannot determine whether exposure preceded or resulted from disease. Case-control Good for diseases with long latency periods and for rare disease, time- and cost-efficient, can examine multiple etiologic factors for a single disease. Good for rare diseases, temporal relationship between exposure and disease difficult to establish, results may be biased (selection and recall). Cohort Good for rare exposures, can assess multiple effects of a single exposure and temporal relationship between exposure and disease, minimizes bias, allows for determination of disease incidence rates. Not good for rare diseases, expensive and time-consuming (prospective), requires availability of adequate records (retrospective), susceptible to loss to follow up. Source: Nielsen and Jensen (2005).
  • 19.  Dozens of studies relating blood lead and neurobehavior/cognitive development in humans and animals  Dating from the late 1970’s  Key studies/reviews ◦ Needleman and Gatsonis (1990) – Low-level Lead Exposure and the IQ of Children. A Meta-analysis of Modern Studies (JAMA 263:673-678) ◦ Canfield et al. (2003a) – Intellectual Impairment in Children with Blood Lead Concentrations Below 10 µg per Deciliter (N Engl J Med 348:1517-1526) ◦ Lanphear et al. (2005) – Low-level Environmental Lead Exposure and Children’s Intellectual Function: An International Pooled Analysis (Environ Health Perspect 113:894–899)
  • 20.  Key reviews/commentary ◦ Kaufman (2001a) – Do Low Levels of Lead Produce IQ Loss in Children?: A Careful Examination of the Literature? (Archives of Clinical Neuropsychology 16:303-341) ◦ Needleman and Bellinger (2001) – Studies of Lead Exposure and the Developing Central Nervous System: A Reply to Kaufman (Archives of Clinical Neuropsychology 16:359-374) ◦ Kaufman (2001b) – How Dangerous are Low (Not Moderate or High) Doses of Lead for Children' s Intellectual Development? (Archives of Clinical Neuropsychology 16:403-431)    Early studies – established the effect Later studies – establishing the effect at increasingly lower PbB “Plaintiff” studies and “Defense” studies
  • 22.     The hypothesis that Pb damages children's brains at low doses is widely accepted There is no safe level of PbB/a linear inverse relationship exists between PbB and intelligence test scores (IQ) – i.e., no threshold Correlations between PbB and IQ are socially relevant Correlations between PbB and IQ remain when confounders were considered
  • 23. The hypothesis that Pb affects IQ at low doses is widely accepted (EPA 2013)    12 major prospective studies, 1992-2011 3 cross-sectional studies, 1987-2011 4 “meta” analyses/pooled studies, 19902005
  • 24. There is no safe level of blood lead/a linear inverse relationship exists between PbB and intelligence test scores (IQ) – i.e., no threshold     Boston cohort – PbB = 1-9.3 μg/dL (Schwartz 1994) Rochester cohort – PbB = 0.5-8.4 μg/dL (Canfield et al. 2003b) Mexico City cohort – PbB = 0.8-4.9 μg/dL (Téllez-Rojo 2008) North Carolina cohort – PbB = 2 μg/dL (Miranda et al. 2009)* *EOG (4th grade) as a surrogate for IQ.
  • 25. Correlations between PbB and IQ are socially relevant (Needleman and Bellinger 2001)      shift of IQ scores occurred across entire distribution of IQ scores  shift in median scores of 6 points associated with 4-fold increase in IQ scores <80 5% of population failed to achieve superior IQ scores >125 Exposures in early childhood associated with 7x increase in high school failure and a 6x increase in reading disabilities
  • 26. Correlations between PbB and IQ remain when confounders were considered (Needleman and Bellinger 2001)    Prospective studies controlled for at least some measure of maternal IQ Most studies controlled for at least global measures of SES; in some cases controlled for home environment more specifically (e.g., via HOME, FACES, etc.) Persons administering the IQ tests in most of the studies were adequately trained in psychometrics
  • 27.     The hypothesis that Pb affects IQ at low doses is controversial There is a level of PbB below which effects on IQ are insignificant – i.e., a threshold Correlations between PbB and IQ are not socially relevant Correlations between PbB and IQ largely disappear when confounders were considered
  • 28. The hypothesis that Pb consistently affects IQ at low doses is controversial     Inconsistency in IQ findings both between studies and within studies (Ernhart 1995) Studies purported to be “low-lead” studies in humans (and animals) are actually moderate- to high-lead studies (Kaufman 2001b) Gender-specific effects – some studies showed > effects in girls than boys; others demonstrated the opposite (Hebben 2001) Although many studies report a significant association between lead and IQ, lead tends to account for a very small amount of variance in IQ (Bellinger and Dietrich 1994)
  • 29. There is a level of PbB below which effects on IQ are insignificant – i.e., a threshold   Assumption of PbB/IQ linearity based not on actual data but rather on dubious regression analyses (Kaufman 2001b) EPA’s Integrated Science Assessment for Lead (EPA 2013) ◦ Lack of a reference population (PbB in pre-industrial population) limits ability to identify a threshold ◦ “. . . the current evidence does not preclude the possibility of a threshold for neurodevelopmental effects in children existing with lower blood levels than those currently examined.”
  • 30. Correlations between PbB and IQ are not socially relevant (Kaufman 2001b)    A few IQ points is well within a reasonable band of error around the observed score The usual IQ loss attributed to low PbB is similar in magnitude to the 2- to 3-point mean gender difference (favoring males) IQ score is meaningless without measurement of other aspects of intellectual functioning – e.g., creativity, social intelligence, practical intelligence, adaptive behavior, mechanical ability, etc.
  • 31. Correlations between PbB and IQ largely disappear when confounders were considered (Kaufman 2001a and b)  For the 26 PbB/IQ studies where confounders may have affected the results: ◦ ◦ ◦ ◦ ◦ 12 used only a global assessment of SES 17 used a “poor” or no measure of maternal IQ 24 did not test father’s IQ 24 did not control for persistent otitis media 18 did not control for pregnancy risk factors (e.g., maternal drug use/abuse, smoking)
  • 32. Difference in Maternal IQ Scores Difference in HOME Scores Difference in Parental Years of Education 7.5 3.6 0.75 7.58 9.42 11.27 1.5 9.11 10.96 12.81 2.25 10.65 12.50 14.35 0.75 11.77 13.62 15.46 1.5 13.30 15.15 17.00 2.25 14.84 16.69 18.54 0.75 15.96 17.81 19.65 1.5 17.50 19.34 21.19 2.25 19.03 20.88 22.73 7.2 10.8 15 22.5 Difference in Child IQ Scores Source: Mink et al. (2004).
  • 33.  An additional “threat” to the validity of the Pb/IQ studies are variables associated with intelligence that are either unknown or unmeasurable – the “Flynn effect” (Kaufman 2001a) ◦ 3 point-per-decade gain in IQ beginning in the 1930’s and continuing to this day ◦ Exposure to technology/mass media? ◦ Parenting/increased awareness of importance of providing cognitive stimulation in infancy? ◦ Improved nutrition?
  • 34.         Bellinger, D., and Dietrich, K. N. 1994. Low-level lead exposure and cognitive function in children. Pediatric Annals 23:601-605. Canfield, R.L., Henderson, C.R. Jr., Cory-Slechta, D.A., Cox, C., Jusko, T.A., and Lanphear, B.P. 2003a. Intellectual Impairment in children with blood lead concentrations below 10 µg per deciliter. N Engl J Med 348:1517-1526. Canfield, R.L.., Kreher, D.A., Cornwell, C., and Henderson, C.R., Jr. 2003b. Low-level lead exposure, executive functioning, and learning in early childhood. Child Neuropsychol 9:35-53. EPA. 2013. Integrated Science Assessment for Lead. EPA/600/R-10/075F. Office of Research and Development, National Center for Environmental Assessment, Research Triangle Park, NC. Ernhart, C.B. 1995. Inconsistencies in the lead-effects literature exist and cannot be explained by "effect modification". Neurotoxicol Teratol. 17(3):227-233. Hebben, H. 2001. Low lead levels and neuropsychological assessment: Let us not be mislead. Archives of Clinical Neuropsychology 16:353-357. Kaufman, A.S. 2001a. Do low levels of lead produce IQ loss in children?: A careful examination of the literature? Archives of Clinical Neuropsychology 16:303-341. Kaufman, A.S. 2001b. How dangerous are low (not moderate or high) doses of lead for children' s intellectual development? Archives of Clinical Neuropsychology 16:403-431.
  • 35.        Lanphear, B.P., Hornung, R., Khoury, J., Yolton, K., Baghurst, P., Bellinger, D.C., Canfield, R.L., Dietrich, K.N., Bornschein, R., Greene, T., Rothenberg, S.J., Needleman, H.L., Schnaas, L., Wasserman, G., Graziano, J., and Roberts, R. 2005. Low-level environmental lead exposure and children’s intellectual function: An international pooled analysis (Environ Health Perspect 113:894–899. Mink, P.J., Goodman, M., Barraj, L.M., Imrey, H., Kelsh, M.A., and Yager. J. 2004. Evaluation of uncontrolled confounding in studies of environmental exposures and neurobehavioral testing in children. Epidemiology 15(4):385-393. Miranda, M.L., Kim, D., Reiter, J., Overstreet Galeano, MA., and Maxson, P. 2009. Environmental contributors to the achievement gap. Neurotoxicology 30:10191024. Needleman, H.L., and Bellinger, D. 2001. Studies of lead exposure and the developing central nervous system: A reply to Kaufman. Archives of Clinical Neuropsychology 16:359-374. Needleman, H.L., and Gatsonis, C.A. 1990. Low-level lead exposure and the IQ of children. A meta-analysis of modern studies. JAMA 263(5):673-678. Nielsen, J.B. and Jensen, T.K. 2005. Environmental Epidemiology. In: Essentials of Medical Geology – Impacts of the Natural Environment on Public Health. O. Selinus, Ed. Elsevier. Schwartz, J. 1994. Low-level lead exposure and children's IQ: A meta-analysis and search for a threshold. Environ Res 65:42-55..
  • 36.  Téllez-Rojo, M.M., Bellinger, D.C., Arroyo-Quiroz, C., Lamadrid-Figueroa, H., Mercado-Garcia, A., Schnaas-Arrieta, L., Wright, RO., Hernandez-Avila, M., and Hu, H. 2006. Longitudinal associations between blood lead concentrations lower than 10 microg/dL and neurobehavioral development in environmentally exposed children in Mexico City. Pediatrics 118:e323-e330.
  • 37. EPIDEMIOLOGIC STUDIES FOR LEAD WHAT ARE THEY GOOD FOR?
  • 38. • Can epidemiologic studies be used “across the board” to determine whether lead has affected a particular individual?
  • 40. • Population based studies • They were not designed – nor could they be – to determine whether a specific child has been affected by lead exposure
  • 41. Does A equal B? 1. Do all smokers get lung cancer? 2. Do all football players sustain brain injuries?
  • 42. • Epidemiologic Studies may show “general causation” • They cannot, by themselves, get to specific causation in an individual.
  • 43. • Lead and IQ – is there a correlation? 1. Is pre-morbid IQ testing necessary?
  • 44. a. In order to make an intelligent assessment of whether an individual has lost IQ points as a result of exposure to lead there must be a baseline. b.Studies that claim to quantify IQ loss as a result of exposure to lead are speculative.
  • 45. c. Not possible to “assign” a loss of IQ with any elevated lead level – only a comparison between preinjury testing and postinjury assessment can yield a true measure of intellectual change.
  • 46. d. Full scale IQ measure can be unreliable for determining a person’s actual level of cognitive capability. e. Neuropsychological testing is used to test areas involving memory, attention , executive functions, verbal fluency.
  • 47. f. How does an individual test in these areas? Have to look “behind the numbers” g. If a child scores low, medium or high on any test – does not mean they would have scored otherwise had there been no lead exposure
  • 48. • There is no specific/single neuropsychological test or result that allows for the conclusion that a specific child’s lead exposure had any impact.
  • 49. 2. Confounding Variables Significant and wellknown risk factors for the development of cognitive difficulties mirror claims of lead exposure:
  • 50. a. Low birth weight b.Maternal pregnancy issues – drugs/alcohol in utero exposure c. Prenatal smoking
  • 51. d. Parental involvement e. Structured environment/lack thereof f. Abuse issues 1) Mental 2) Physical 3) Sexual
  • 52. h. Potential foster care i. Outside influences j. Drug Use by individuals k. Depression/anxiety
  • 53. • Each individual different – cannot “control” for all variables • Fallacy of argument that confounding factors are being counted twice
  • 54. 3. School Performance a. Attendance – school and specific classes b. Homework completion c. Extra help
  • 55. d. e. f. g. Behavior problems Discipline problems Drug use Frequent changes in school – disruptive learning
  • 56. Conclusion General population studies are just that, not capable of being used to determine that any individual has been affected by alleged exposure to lead.
  • 59.  ONE OF THE LONGEST EPIDEMIOLOGICAL LONGITUDINAL STUDIES! Quit smoking on the advice of your physician?  Epidemiological research. Take Tamiflu in 2009?  Epidemiological research.
  • 60.   Lead is the most well studied toxin in history. International pooled analysis: ◦ Data, not average of averages. ◦ Seven participating sites:         Boston, Mass. Cincinnati, Ohio Cleveland, Ohio Mexico City, Mexico Port Pirie, Australia Rochester, NY Yugoslovia Approximately 1,300 children.
  • 61.  International Pooled Analysis ◦ ◦ ◦ ◦ ◦ ◦ ◦ ◦ ◦ ◦ HOME Inventory Sex Birth weight Birth order Maternal education Maternal IQ Maternal age Marital status Prenatal smoking status Prenatal alcohol use
  • 62.  Q And I think you had said it once best, and tell if it sounds -- you said this, but just tell me if you still agree with it, the researchers control for those factors so that the conclusion of their study is specific to what is the measurable effect that lead has on IQ loss? A Correct. Q And that's in the context of the pooled analysis. And for Needleman, it would be the researchers controlled for those factors so the conclusion of their study is specific to what is the measurable effect that lead has on behavior? A Correct. Q And so it's incorrect to assume that in order to reach the opinions you have in this case, that you need administer the HOME test to the plaintiffs to determine whether or not their lead exposure caused them IQ loss? A That's correct. Q It's already been done. That's the point. A Well, and I'm only giving opinions about what IQ loss I would attribute using this type of medical literature to this particular child. Q And I know it sounds pedantic. Just work with me here. But the point that I'm making is that you don't have to go back in the forensic context and control for all these variables again. That's why the researchers did it in the first place? MR. [Lawyer for the Defendant]: Objection.  A           That's correct. Yes. I agree with that.
  • 63.   If only Johnny with his 65 IQ, reading disorder and ADHD wouldn’t have missed 30 days his 4th time in 9th grade, it would have all worked out okay. Hammond et al., May 2007 ◦ Among the top risk factors for dropping out of middle school and high school:  Learning disabled  Low academic achievement  Retention/over-age for grade  Multiple retentions have additive effects, dramatically increasing the risk of dropping out.
  • 65.                 Dr. Cris A. Williams Ph.D., Senior Science Advisor ENVIRON 850.668.3551 cwilliams@environcorp.com Gary Abelson Hiscock & Barclay LLP 585.295.8411 gabelson@hblaw.com Nicholas Szokoly Law Offices of Evan K. Thalenberg, P.A. 410.625.9200 nszokoly@ektlaw.com Dr. Karl Kieburtz MD, MPH University of Rochester Medical Center 585.275.8762 Karl.Kieburtz@chet.rochester.edu